Safety and protection of plasma donors: A scoping review and evidence gap map

N Schroyens, T D'aes, E De Buck, S Mikkelsen… - Vox …, 2024 - Wiley Online Library
Abstract Background and Objectives As part of a large‐scale project to safely increase
plasma collection in Europe, the current scoping review identifies the existing evidence …

Haemovigilance: current practices and future developments

LL de Jonge, JC Wiersum-Osselton, AG Bokhorst… - Annals of …, 2022 - research.rug.nl
Haemovigilance is the systematic surveillance of adverse events in the transfusion chain,
and encompasses activities that contribute to the safety and quality in the process of blood …

Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020

X Tian, Y Kong, J Wang, R He, L Li, Z Liu… - Vox …, 2022 - Wiley Online Library
Abstract Background and Objectives To advance blood transfusion safety, the Chinese
Haemovigilance Network (CHN) was put into operation in 2018. This report describes the …

Demographics of first‐time donors returning for donation during the pandemic: COVID‐19 convalescent plasma versus standard blood product donors

NL Van Buren, S Rajbhandary, V Reynolds… - …, 2023 - Wiley Online Library
Background Previous studies have demonstrated low first‐time donor return rates (DRR)
following catastrophic events. Little is known, however, about the influence of demographic …

献血不良反应严重程度分级标准及其应用进展

杨俊鸿, 代华友, 杨冬燕, 黄霞 - 临床输血与检验, 2024 - lcsxyjy.com
近年来, 随着献血者安全监测工作的不断深入, 献血不良反应作为献血者安全监测的核心内容之
一得到了广泛关注. 明确, 统一的定义是开展献血不良反应监测的基础, 也是不同单位, 地区 …

Ensuring Safe Transfusion Practices through Haemovigilance: India vis-a-vis Global Scenario

R Rana, SR Veluri Kishore, G Kaur, G Singh… - Current Drug …, 2023 - benthamdirect.com
Haemovigilance is the monitoring of the essential components of blood transfusion from its
initial stages to the final outcome considering all the safety parameters and hazards that co …

A male Covid-19 convalescent plasma donor with long existence of SARS-Cov-2 antibodies: a case report

T Triyono, U Sukorini, A Christianalusi… - JKKI: Jurnal …, 2023 - journal.uii.ac.id
Abstract Covid-19 Convalescent Plasma (CCP) was one of alternative therapy for Covid-19
patients. The use of convalescent plasma as an adjunct therapy must consider its efficacy …

[HTML][HTML] Evaluating adverse events in COVID-19 recovered convalescent plasma donors: a comprehensive analysis

S Bahadur, B Gupta, S Shukla, S Kalhan… - Iranian Journal of Blood …, 2024 - ijbc.ir
Background: The emergence of the COVID-19 pandemic prompted the exploration of
convalescent plasma therapy (CPT) as a potential treatment modality. This study provides a …

Spendersicherheit bei der Gewinnung von Rekonvaleszentenplasma

JH Cho - thieme-connect.com
Früh übertragenes Rekonvaleszentenplasma mit einem hohen Titer neutralisierender
Antikörper verbesserte bei schwer erkrankten, hospitalisierten Patienten mit COVID-19 die …

The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan

A Kamo-Imai, T Togano, M Sato, Y Kawakami… - … and Apheresis Science, 2023 - Elsevier
Purpose Since 2020, the novel coronavirus infection (COVID-19) has spread globally. A few
studies have investigated the safety of COVID-19 convalescent plasma (CCP) apheresis …